Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
Other Issues:
Previous Next
Contents: Volume 19, Number 3, March 2008   [Index by Author] 

Down in this issue
Down editorial
Down reviews
Down original articles
     urogenital tumors
     supportive care
     breast cancer
     gynecologic tumors
     gastrointestinal tumors
     hematologic malignancies
     quality of life
     oncology practice
     melanoma
Down letters to the editor
Down erratum


[Search ALL Issues]


Table of Contents (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

in this issue Back

in this issue
Annals of Oncology Advance Access published on February 13, 2008
Ann Oncol 2008 19: 405; doi:10.1093/annonc/mdn028 [Extract] [Full Text] [PDF] [Request Permissions]  

editorial Back

A. Horwich
Stage I seminoma and carboplatin risks
Annals of Oncology Advance Access published on January 27, 2008
Ann Oncol 2008 19: 407-408; doi:10.1093/annonc/mdm594 [Extract] [Full Text] [PDF] [Request Permissions]  

P. Marino
Measuring the cost of chemotherapy is important, but it is not enough
Annals of Oncology Advance Access published on January 30, 2008
Ann Oncol 2008 19: 409-410; doi:10.1093/annonc/mdn004 [Extract] [Full Text] [PDF] [Request Permissions]  

reviews Back

H. Mellstedt, D. Niederwieser, and H. Ludwig
The challenge of biosimilars
Annals of Oncology Advance Access published on September 14, 2007
Ann Oncol 2008 19: 411-419; doi:10.1093/annonc/mdm345 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

M. Aapro, P. A. Abrahamsson, J. J. Body, R. E. Coleman, R. Colomer, L. Costa, L. Crinò, L. Dirix, M. Gnant, J. Gralow, P. Hadji, G. N. Hortobagyi, W. Jonat, A. Lipton, A. Monnier, A. H. G. Paterson, R. Rizzoli, F. Saad, and B. Thürlimann
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
Annals of Oncology Advance Access published on September 28, 2007
Ann Oncol 2008 19: 420-432; doi:10.1093/annonc/mdm442 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

R. S. Boersma, K.-S. G. Jie, A. Verbon, E. C. M. van Pampus, and H. C. Schouten
Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies
Annals of Oncology Advance Access published on October 24, 2007
Ann Oncol 2008 19: 433-442; doi:10.1093/annonc/mdm350 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

original articles Back

urogenital tumors Back

T. Powles, D. Robinson, J. Shamash, H. Moller, N. Tranter, and T. Oliver
The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis
Annals of Oncology Advance Access published on November 28, 2007
Ann Oncol 2008 19: 443-447; doi:10.1093/annonc/mdm540 [Abstract] [Full Text] [PDF] [CME/CE] [Request Permissions]  

C. Bokemeyer, K. Oechsle, F. Honecker, F. Mayer, J. T. Hartmann, C. F. Waller, I. Böhlke, and C. Kollmannsberger
Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group
Annals of Oncology Advance Access published on November 15, 2007
Ann Oncol 2008 19: 448-453; doi:10.1093/annonc/mdm526 [Abstract] [Full Text] [PDF] [Request Permissions]  

supportive care Back

D. Weycker, J. Malin, J. Edelsberg, A. Glass, M. Gokhale, and G. Oster
Cost of neutropenic complications of chemotherapy
Annals of Oncology Advance Access published on December 13, 2007
Ann Oncol 2008 19: 454-460; doi:10.1093/annonc/mdm525 [Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

breast cancer Back

T. Vu, S. Ellard, C. H. Speers, S. C. M. Taylor, M. L. de Lemos, F. Hu, K. Kuik, and I. A. Olivotto
Survival outcome and cost-effectiveness with docetaxel and paclitaxel in patients with metastatic breast cancer: a population-based evaluation
Annals of Oncology Advance Access published on November 15, 2007
Ann Oncol 2008 19: 461-464; doi:10.1093/annonc/mdm527 [Abstract] [Full Text] [PDF] [Request Permissions]  

M. Colleoni, G. Viale, D. Zahrieh, L. Bottiglieri, R. D. Gelber, P. Veronesi, A. Balduzzi, R. Torrisi, A. Luini, M. Intra, S. Dellapasqua, A. Cardillo, R. Ghisini, G. Peruzzotti, and A. Goldhirsch
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy
Annals of Oncology Advance Access published on November 6, 2007
Ann Oncol 2008 19: 465-472; doi:10.1093/annonc/mdm509 [Abstract] [Full Text] [PDF] [Request Permissions]  

S. I. Labidi, K. Mrad, A. Mezlini, M. Ayadi Ouarda, J. D. Combes, M. Ben Abdallah, K. Ben Romdhane, P. Viens, and F. Ben Ayed
Inflammatory breast cancer in Tunisia in the era of multimodality therapy
Annals of Oncology Advance Access published on November 15, 2007
Ann Oncol 2008 19: 473-480; doi:10.1093/annonc/mdm480 [Abstract] [Full Text] [PDF] [Request Permissions]  

R. Ng, G. R. Pond, P. A. Tang, P. W. MacIntosh, L. L. Siu, and E. X. Chen
Correlation of changes between 2-year disease-free survival and 5-year overall survival in adjuvant breast cancer trials from 1966 to 2006
Annals of Oncology Advance Access published on November 20, 2007
Ann Oncol 2008 19: 481-486; doi:10.1093/annonc/mdm486 [Abstract] [Full Text] [PDF] [Request Permissions]  

M. Lidgren, B. Jönsson, C. Rehnberg, N. Willking, and J. Bergh
Cost-effectiveness of HER2 testing and 1-year adjuvant trastuzumab therapy for early breast cancer
Annals of Oncology Advance Access published on December 6, 2007
Ann Oncol 2008 19: 487-495; doi:10.1093/annonc/mdm488 [Abstract] [Full Text] [PDF] [Request Permissions]  

F.-C. Bidard, A. Vincent-Salomon, B. Sigal-Zafrani, V. Diéras, C. Mathiot, L. Mignot, J.-P. Thiery, X. Sastre-Garau, and J.-Y. Pierga
Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells
Annals of Oncology Advance Access published on January 10, 2008
Ann Oncol 2008 19: 496-500; doi:10.1093/annonc/mdm507 [Abstract] [Full Text] [PDF] [Request Permissions]  

gynecologic tumors Back

S. Marchini, M. Marabese, E. Marrazzo, P. Mariani, D. Cattaneo, R. Fossati, A. Compagnoni, R. Fruscio, A. A. Lissoni, and M. Broggini
{Delta}Np63 expression is associated with poor survival in ovarian cancer
Annals of Oncology Advance Access published on November 12, 2007
Ann Oncol 2008 19: 501-507; doi:10.1093/annonc/mdm519 [Abstract] [Full Text] [PDF] [Supplementary Material] [Request Permissions]  

gastrointestinal tumors Back

W. De Roock, H. Piessevaux, J. De Schutter, M. Janssens, G. De Hertogh, N. Personeni, B. Biesmans, J.-L. Van Laethem, M. Peeters, Y. Humblet, E. Van Cutsem, and S. Tejpar
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab
Annals of Oncology Advance Access published on November 12, 2007
Ann Oncol 2008 19: 508-515; doi:10.1093/annonc/mdm496 [Abstract] [Full Text] [PDF] [CME/CE] [supplementary data] [Request Permissions]  

P. Muretto, A. Ruzzo, F. Pizzagalli, F. Graziano, P. Maltese, C. Zingaretti, E. Berselli, N. Donnarumma, and M. Magnani
Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients
Annals of Oncology Advance Access published on November 6, 2007
Ann Oncol 2008 19: 516-519; doi:10.1093/annonc/mdm493 [Abstract] [Full Text] [PDF] [Request Permissions]  

H.-C. Jeung, Y. W. Moon, S. Y. Rha, N. C. Yoo, J. K. Roh, S. H. Noh, J. S. Min, B. S. Kim, and H. C. Chung
Phase III trial of adjuvant 5-fluorouracil and adriamycin versus 5-fluorouracil, adriamycin, and polyadenylic–polyuridylic acid (poly A:U) for locally advanced gastric cancer after curative surgery: final results of 15-year follow-up
Annals of Oncology Advance Access published on November 20, 2007
Ann Oncol 2008 19: 520-526; doi:10.1093/annonc/mdm536 [Abstract] [Full Text] [PDF] [Request Permissions]  

X.-J. Cheng, W. Xu, Q.-Y. Zhang, and R.-L. Zhou
Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers
Annals of Oncology Advance Access published on October 26, 2007
Ann Oncol 2008 19: 527-532; doi:10.1093/annonc/mdm469 [Abstract] [Full Text] [PDF] [Request Permissions]  

G. Y. Ku, B. D. Minsky, V. W. Rusch, M. Bains, D. P. Kelsen, and D. H. Ilson
Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience
Annals of Oncology Advance Access published on October 17, 2007
Ann Oncol 2008 19: 533-537; doi:10.1093/annonc/mdm476 [Abstract] [Full Text] [PDF] [Request Permissions]  

L. Trümper, C. Zwick, M. Ziepert, K. Hohloch, R. Schmits, M. Mohren, R. Liersch, M. Bentz, U. Graeven, U. Wruck, M. Hoffmann, B. Metzner, D. Hasenclever, M. Loeffler, M. Pfreundschuh, and On behalf of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens
Annals of Oncology Advance Access published on January 22, 2008
Ann Oncol 2008 19: 538-544; doi:10.1093/annonc/mdm497 [Abstract] [Full Text] [PDF] [Request Permissions]  

hematologic malignancies Back

M. Pfreundschuh, C. Zwick, S. Zeynalova, U. Dührsen, K.-H. Pflüger, T. Vrieling, R. Mesters, H.-G. Mergenthaler, H. Einsele, M. Bentz, E. Lengfelder, L. Trümper, C. Rübe, N. Schmitz, and M. Loeffler On behalf of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin’s lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL)
Annals of Oncology Advance Access published on December 6, 2007
Ann Oncol 2008 19: 545-552; doi:10.1093/annonc/mdm514 [Abstract] [Full Text] [PDF] [Request Permissions]  

M. J. Overman, L. Feng, B. Pro, P. McLaughlin, M. Hess, F. Samaniego, A. Younes, J. E. Romaguera, F. B. Hagemeister, L. Kwak, F. Cabanillas, M. A. Rodriguez, and L. E. Fayad
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma
Annals of Oncology Advance Access published on December 13, 2007
Ann Oncol 2008 19: 553-559; doi:10.1093/annonc/mdm511 [Abstract] [Full Text] [PDF] [Request Permissions]  

P. Morel, P. Gaulard, C. Gisselbrecht, C. Ferme, G. Salles, H. Tilly, J. Brière, M. C. Copin, P. Lederlin, O. Hermine, I. Theate, C. Haioun, and N. Mounier
Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2
Annals of Oncology Advance Access published on December 19, 2007
Ann Oncol 2008 19: 560-565; doi:10.1093/annonc/mdm520 [Abstract] [Full Text] [PDF] [Request Permissions]  

P. Adam, B. Schmausser, M. Göbeler-Kolve, H. K. Müller-Hermelink, and M. Eck
Gastric extranodal marginal zone B-cell lymphomas of MALT type exclusively express toll-like receptor 4 in contrast to other lymphomas infiltrating the stomach
Annals of Oncology Advance Access published on November 27, 2007
Ann Oncol 2008 19: 566-569; doi:10.1093/annonc/mdm485 [Abstract] [Full Text] [PDF] [Request Permissions]  

quality of life Back

R. Pettengell, C. Donatti, P. Hoskin, C. Poynton, P. J. Kettle, B. Hancock, S. Johnson, M. J. S. Dyer, S. Rule, M. Walker, and D. Wild
The impact of follicular lymphoma on health-related quality of life
Annals of Oncology Advance Access published on December 3, 2007
Ann Oncol 2008 19: 570-576; doi:10.1093/annonc/mdm543 [Abstract] [Full Text] [PDF] [Request Permissions]  

oncology practice Back

B. D. Badgwell, E. R. Camp, B. Feig, R. A. Wolff, C. Eng, L. M. Ellis, and J. N. Cormier
Management of bevacizumab-associated bowel perforation: a case series and review of the literature
Annals of Oncology Advance Access published on November 16, 2007
Ann Oncol 2008 19: 577-582; doi:10.1093/annonc/mdm508 [Abstract] [Full Text] [PDF] [Request Permissions]  

melanoma Back

E. de Vries, T. E. C. Nijsten, O. Visser, E. Bastiaannet, S. van Hattem, M. L. Janssen-Heijnen, and J. -W. W. Coebergh
Superior survival of females among 10 538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site
Annals of Oncology Advance Access published on October 31, 2007
Ann Oncol 2008 19: 583-589; doi:10.1093/annonc/mdm498 [Abstract] [Full Text] [PDF] [Request Permissions]  

M. M. McCarthy, E. Pick, Y. Kluger, B. Gould-Rothberg, R. Lazova, R. L. Camp, D. L. Rimm, and H. M. Kluger
HSP90 as a marker of progression in melanoma
Annals of Oncology Advance Access published on November 23, 2007
Ann Oncol 2008 19: 590-594; doi:10.1093/annonc/mdm545 [Abstract] [Full Text] [PDF] [Request Permissions]  

letters to the editor Back

P.-Y. Dietrich and M. A. Duchosal
Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome
Annals of Oncology Advance Access published on January 21, 2008
Ann Oncol 2008 19: 595; doi:10.1093/annonc/mdm602 [Extract] [Full Text] [PDF] [Request Permissions]  

P. H. Cottu, J. Asselah, M. Lae, J.-Y. Pierga, V. Diéras, L. Mignot, B. Sigal-Zafrani, and A. Vincent-Salomon
Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer
Annals of Oncology Advance Access published on February 13, 2008
Ann Oncol 2008 19: 595-597; doi:10.1093/annonc/mdn021 [Extract] [Full Text] [PDF] [Request Permissions]  

J.-P. Machiels, N. Bletard, P. Pirenne, L. Jacquet, F. Bonbled, and L. Duck
Acute cardiac failure after sunitinib
Annals of Oncology Advance Access published on February 13, 2008
Ann Oncol 2008 19: 597-599; doi:10.1093/annonc/mdn019 [Extract] [Full Text] [PDF] [Request Permissions]  

M. Biasotto
Numb chin syndrome as the presenting symptom of carcinomatous meningitis
Ann Oncol 2008 19: 599-601; doi:10.1093/annonc/mdn027 [Extract] [Full Text] [PDF] [Request Permissions]  

erratum Back

Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases
Ann Oncol 2008 19: 601; doi:10.1093/annonc/mdm584 [Extract] [Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.